SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $224,000 | -23.5% | 1,600 | 0.0% | 0.04% | -23.4% |
Q2 2019 | $293,000 | +15.4% | 1,600 | 0.0% | 0.05% | +14.6% |
Q1 2019 | $254,000 | +66.0% | 1,600 | 0.0% | 0.04% | +46.4% |
Q4 2018 | $153,000 | -32.3% | 1,600 | 0.0% | 0.03% | -20.0% |
Q3 2018 | $226,000 | -9.6% | 1,600 | 0.0% | 0.04% | -14.6% |
Q2 2018 | $250,000 | -13.8% | 1,600 | -11.1% | 0.04% | -12.8% |
Q1 2018 | $290,000 | -2.7% | 1,800 | -0.6% | 0.05% | +4.4% |
Q4 2017 | $298,000 | +127.5% | 1,810 | -13.8% | 0.04% | +104.5% |
Q3 2017 | $131,000 | -21.6% | 2,100 | 0.0% | 0.02% | -38.9% |
Q2 2017 | $167,000 | – | 2,100 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |